Pivotal: Pivotal to Provide Specialized Services for Trial with COVID-19 Patients

Pivotal has announced that it will provide specialized clinical research services in a clinical trial to study the efficacy and safety of hyperimmune plasma in the treatment of hospitalized patients with COVID-19. The two-phase study is a multicenter, randomized, sequential and adaptive design c